Literature DB >> 16906286

Effect of the consumption of tomato paste on plasma prostate-specific antigen levels in patients with benign prostate hyperplasia.

M S Edinger1, W J Koff.   

Abstract

The consumption of tomatoes and tomato products has been associated with a reduced risk of prostate cancer. We observed a decrease of 10.77% in prostate-specific antigen (PSA) levels in patients with benign prostate hyperplasia who were submitted to daily ingestion of tomato paste. This was an experimental rather than a controlled study with a sample of 43 men ranging in age from 45 to 75 years, all with histological diagnoses of benign prostate hyperplasia and plasma PSA levels of 4-10 ng/mL. All patients received 50 g of tomato paste once a day for 10 consecutive weeks and PSA levels were analyzed before, during and after the consumption of tomato paste. ANOVA for repeated measures was used to compare PSA levels before, during and after the consumption of tomato paste. The mean +/- SD PSA level was 6.51 +/- 1.48 ng/mL at baseline and 5.81 +/- 1.58 ng/mL (P = 0.005) after 10 weeks. Acceptance was good in 88.3, regular in 9.3, and poor in 2.3% of the patients. Dietary ingestion of 50 g of tomato paste per day for 10 weeks significantly reduced mean plasma PSA levels in patients with benign prostate hyperplasia, probably as a result of the high amount of lycopene in tomato paste. This was not a prostate cancer prevention study, but showed some action of tomato paste in prostate biology. The development of prostate cancer is typically accompanied by an increase in plasma PSA levels, thus any intervention that affects plasma PSA levels can suggest an impact in the progression of disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906286     DOI: 10.1590/s0100-879x2006000800014

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  8 in total

Review 1.  Diet and prostate cancer: mechanisms of action and implications for chemoprevention.

Authors:  Vasundara Venkateswaran; Laurence H Klotz
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 2.  Food-based natural products for cancer management: Is the whole greater than the sum of the parts?

Authors:  Suleman S Hussain; Addanki P Kumar; Rita Ghosh
Journal:  Semin Cancer Biol       Date:  2016-07-07       Impact factor: 15.707

Review 3.  [Primary and secondary prevention of benign prostatic hyperplasia: current knowledge and implications for clinical management].

Authors:  M Oelke; S Madersbacher
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

4.  Associations of serum vitamin A and carotenoid levels with markers of prostate cancer detection among US men.

Authors:  Hind A Beydoun; Monal R Shroff; Ravinder Mohan; May A Beydoun
Journal:  Cancer Causes Control       Date:  2011-07-29       Impact factor: 2.506

Review 5.  Are the health attributes of lycopene related to its antioxidant function?

Authors:  John W Erdman; Nikki A Ford; Brian L Lindshield
Journal:  Arch Biochem Biophys       Date:  2008-11-01       Impact factor: 4.013

6.  Differential bioavailability, clearance, and tissue distribution of the acyclic tomato carotenoids lycopene and phytoene in mongolian gerbils.

Authors:  Nancy Engelmann Moran; Steven K Clinton; John W Erdman
Journal:  J Nutr       Date:  2013-10-09       Impact factor: 4.798

7.  Carotenoid profile of tomato sauces: effect of cooking time and content of extra virgin olive oil.

Authors:  Anna Vallverdú-Queralt; Jorge Regueiro; José Fernando Rinaldi de Alvarenga; Xavier Torrado; Rosa M Lamuela-Raventos
Journal:  Int J Mol Sci       Date:  2015-04-28       Impact factor: 5.923

Review 8.  Treatment of Benign Prostatic Hyperplasia by Natural Drugs.

Authors:  Eszter Csikós; Adrienn Horváth; Kamilla Ács; Nóra Papp; Viktória Lilla Balázs; Marija Sollner Dolenc; Maša Kenda; Nina Kočevar Glavač; Milan Nagy; Michele Protti; Laura Mercolini; Györgyi Horváth; Ágnes Farkas
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.